Follow the Addex Therapeutics Ltd share price and the full directors' dealings record of the company, a listed issuer based in Switzerland. Shares are quoted on the CH market, under the authority of SIX SER. Operating in the Health Care sector, Addex Therapeutics Ltd has published 9 reports. Market capitalisation: €6.2m. The latest transaction was disclosed on 27 November 2023 (Purchase). All data is accessible without an account.
9
Insider Decl.
n/a
Thresholds
€502,776
9 ops.
Buy Volume
n/a
n/a
Sell Volume
37Σ signal
Buys €502,776n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 27 November 2023
Declarations9 total
●
Anonymous (Non-executive member of the board of directors)
Non-executive member of the board of directors·Executives·
50,000 shares@ CHF 0.0430.040% mcap0.5% of flowISINISIN CH0029850754SIX:T1NBR000G3
9 of 9 declarations
About Addex Therapeutics Ltd
Addex Therapeutics Ltd is a biopharmaceutical company focused on developing treatments for neurological and psychiatric disorders. It is listed on the Swiss stock exchange XSWX.